Home
Conditions
Myelodysplastic/Myeloproliferative Diseases

Clinical trial condition

Myelodysplastic/Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic/Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

49 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic/Myeloproliferative Diseases trial results

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

NCT00006225

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Breast Cancer, +67 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

NCT00281801

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +63 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

NCT00003335

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

NCT00006379

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +100 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes

NCT00093366

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +14 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

NCT00089037

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

NCT00002809

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Fox Chase-Temple Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients

NCT00082654

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +108 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00062140

Conditions: Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +51 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder

NCT00049634

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

Seattle Cancer Care Alliance Seattle, Washington, United States

View Trial Details

Myelodysplastic/Myeloproliferative Diseases

Myelodysplastic/Myeloproliferative Diseases trial results

Related conditions